AAAAAA

   
Results: 1-16 |
Results: 16
COST-EFFECTIVENESS OF DIRECTLY OBSERVED CHEMOPROPHYLAXIS OF TUBERCULOSIS AMONG DRUG-USERS AT HIGH-RISK FOR TUBERCULOSIS
Authors: GOUREVITCH MN ALCABES P WASSERMAN WC ARNO PS
Citation: Mn. Gourevitch et al., COST-EFFECTIVENESS OF DIRECTLY OBSERVED CHEMOPROPHYLAXIS OF TUBERCULOSIS AMONG DRUG-USERS AT HIGH-RISK FOR TUBERCULOSIS, The international journal of tuberculosis and lung disease, 2(7), 1998, pp. 531-540
HETEROZYGOTE FREQUENCY FOR GLYCOGENOSIS TYPE-II IN ITALY
Authors: DANESINO C MARTINIUK F DELLAVECCHIA C CHEN A MACK A ARVANITOPOULOS E MINELLI A ALCABES P ROM WN
Citation: C. Danesino et al., HETEROZYGOTE FREQUENCY FOR GLYCOGENOSIS TYPE-II IN ITALY, European journal of human genetics, 6, 1998, pp. 4213-4213
LETTER TO THE EDITOR - CARRIER FREQUENCY FOR GLYCOGEN-STORAGE-DISEASETYPE-II IN NEW-YORK AND ESTIMATES OF AFFECTED INDIVIDUALS BORN WITH THE DISEASE
Authors: MARTINIUK F CHEN A MACK A ARVANITOPOULOS E CHEN Y ROM WN CODD WJ HANNA B ALCABES P RABEN N PLOTZ P
Citation: F. Martiniuk et al., LETTER TO THE EDITOR - CARRIER FREQUENCY FOR GLYCOGEN-STORAGE-DISEASETYPE-II IN NEW-YORK AND ESTIMATES OF AFFECTED INDIVIDUALS BORN WITH THE DISEASE, American journal of medical genetics, 79(1), 1998, pp. 69-72
GEOGRAPHIC DIVERSITY IN TUBERCULOSIS TRENDS AND DIRECTLY OBSERVED THERAPY, NEW-YORK-CITY, 1991 TO 1994
Authors: DAVIDOW AL MARMOR M ALCABES P
Citation: Al. Davidow et al., GEOGRAPHIC DIVERSITY IN TUBERCULOSIS TRENDS AND DIRECTLY OBSERVED THERAPY, NEW-YORK-CITY, 1991 TO 1994, American journal of respiratory and critical care medicine, 156(5), 1997, pp. 1495-1500
LOW SERUM THIOL LEVELS PREDICT SHORTER TIMES-TO-DEATH AMONG HIV-INFECTED INJECTING DRUG-USERS
Authors: MARMOR M ALCABES P TITUS S FRENKEL K KRASINSKI K PENN A PERO RW
Citation: M. Marmor et al., LOW SERUM THIOL LEVELS PREDICT SHORTER TIMES-TO-DEATH AMONG HIV-INFECTED INJECTING DRUG-USERS, AIDS, 11(11), 1997, pp. 1389-1393
LONG-TERM PERSPECTIVE ON THE PREVALENT-COHORT BIASES IN STUDIES OF HUMAN-IMMUNODEFICIENCY-VIRUS PROGRESSION
Authors: ALCABES P PEZZOTTI P PHILLIPS AN REZZA G VLAHOV D
Citation: P. Alcabes et al., LONG-TERM PERSPECTIVE ON THE PREVALENT-COHORT BIASES IN STUDIES OF HUMAN-IMMUNODEFICIENCY-VIRUS PROGRESSION, American journal of epidemiology, 146(7), 1997, pp. 543-551
USE OF A QUANTITATIVE CYTOMEGALOVIRUS (CMV) ANTIGENEMIA TEST IN EVALUATING HIV+ PATIENTS WITH AND WITHOUT CMV DISEASE
Authors: WETHERILL PE LANDRY ML ALCABES P FRIEDLAND G
Citation: Pe. Wetherill et al., USE OF A QUANTITATIVE CYTOMEGALOVIRUS (CMV) ANTIGENEMIA TEST IN EVALUATING HIV+ PATIENTS WITH AND WITHOUT CMV DISEASE, Journal of acquired immune deficiency syndromes and human retrovirology, 12(1), 1996, pp. 33-37
EFFECT OF STAVUDINE ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIRUS LOADAS MEASURED BY QUANTITATIVE MONONUCLEAR CELL-CULTURE, PLASMA RNA, ANDIMMUNE COMPLEX-DISSOCIATED ANTIGENEMIA
Authors: GRIFFITH BP BRETTSMITH H KIM G MELLORS JW CHACKO TM GARNER RB CHENG YC ALCABES P FRIEDLAND G
Citation: Bp. Griffith et al., EFFECT OF STAVUDINE ON HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 VIRUS LOADAS MEASURED BY QUANTITATIVE MONONUCLEAR CELL-CULTURE, PLASMA RNA, ANDIMMUNE COMPLEX-DISSOCIATED ANTIGENEMIA, The Journal of infectious diseases, 173(5), 1996, pp. 1252-1255
INJECTION-DRUG USE AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION
Authors: ALCABES P FRIEDLAND G
Citation: P. Alcabes et G. Friedland, INJECTION-DRUG USE AND HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION, Clinical infectious diseases, 20(6), 1995, pp. 1467-1479
LABORATORY MARKERS AND THE RISK OF DEVELOPING HIV-1 DISEASE AMONG INJECTING DRUG-USERS (VOL 8, PG 107, 1994)
Authors: ALCABES P SELWYN PA DAVENNY K HARTEL D BUONO D SCHOENBAUM EE KLEIN RS FRIEDLAND GH
Citation: P. Alcabes et al., LABORATORY MARKERS AND THE RISK OF DEVELOPING HIV-1 DISEASE AMONG INJECTING DRUG-USERS (VOL 8, PG 107, 1994), AIDS, 8(4), 1994, pp. 566-566
LABORATORY MARKERS AND THE RISK OF DEVELOPING HIV-1 DISEASE AMONG INJECTING DRUG-USERS
Authors: ALCABES P SELWYN PA DAVENNY K HARTEL D BUONO D SCHOENBAUM EE KLEIN RS FRIEDLAND GH
Citation: P. Alcabes et al., LABORATORY MARKERS AND THE RISK OF DEVELOPING HIV-1 DISEASE AMONG INJECTING DRUG-USERS, AIDS, 8(1), 1994, pp. 107-115
CHILDHOOD TUBERCULOSIS IN THE BRONX, NEW-YORK
Authors: DRUCKER E ALCABES P BOSWORTH W SCKELL B
Citation: E. Drucker et al., CHILDHOOD TUBERCULOSIS IN THE BRONX, NEW-YORK, Lancet, 343(8911), 1994, pp. 1482-1485
CD4-DRUG-USERS WITH HIV-INFECTION( LYMPHOCYTE LEVEL AND RATE OF DECLINE AS PREDICTORS OF AIDS IN INTRAVENOUS)
Authors: ALCABES P SCHOENBAUM EE KLEIN RS
Citation: P. Alcabes et al., CD4-DRUG-USERS WITH HIV-INFECTION( LYMPHOCYTE LEVEL AND RATE OF DECLINE AS PREDICTORS OF AIDS IN INTRAVENOUS), AIDS, 7(4), 1993, pp. 513-517
INCUBATION PERIOD OF HUMAN-IMMUNODEFICIENCY-VIRUS
Authors: ALCABES P MUNOZ A VLAHOV D FRIEDLAND GH
Citation: P. Alcabes et al., INCUBATION PERIOD OF HUMAN-IMMUNODEFICIENCY-VIRUS, Epidemiologic reviews, 15(2), 1993, pp. 303-318
ANERGY COMPROMISES SCREENING FOR TUBERCULOSIS IN HIGH-RISK POPULATIONS
Authors: ZOLOTH SR SAFYER S ROSEN J MICHAELS D ALCABES P BELLIN E BRASLOW C
Citation: Sr. Zoloth et al., ANERGY COMPROMISES SCREENING FOR TUBERCULOSIS IN HIGH-RISK POPULATIONS, American journal of public health, 83(5), 1993, pp. 749-751
CORRELATES OF THE RATE OF DECLINE OF CD4-DRUG USERS INFECTED WITH THEHUMAN-IMMUNODEFICIENCY-VIRUS( LYMPHOCYTES AMONG INJECTION)
Authors: ALCABES P SCHOENBAUM EE KLEIN RS
Citation: P. Alcabes et al., CORRELATES OF THE RATE OF DECLINE OF CD4-DRUG USERS INFECTED WITH THEHUMAN-IMMUNODEFICIENCY-VIRUS( LYMPHOCYTES AMONG INJECTION), American journal of epidemiology, 137(9), 1993, pp. 989-1000
Risultati: 1-16 |